ACT for People With Dementia Experiencing Psychological Distress
Acceptance and Commitment Therapy (ACT) for People With Dementia Experiencing Psychological Distress: a Hermeneutic Single Case Efficacy Design (HSCED) Series
1 other identifier
interventional
6
1 country
1
Brief Summary
Introduction: People with dementia have a high prevalence of psychological distress but are under-served with evidence-based psychological interventions. To promote choice and improve clinical outcomes, there is a necessity to test different psychological intervention options for this population. Purpose: To investigate the effectiveness and acceptability of Acceptance and Commitment Therapy (ACT) for people with dementia, considering carer-supported, remote delivery and necessary therapy adaptations. Methods: A hermeneutic single case efficacy design (HSCED) series was used to analyse therapy process and change for three clients with dementia and psychological distress. Quantitative and qualitative data was collated ('rich case records') and analysed by three independent psychotherapy experts ('judges') who determined the outcome for each client. Results: Over the course of therapy, it was concluded that one client with dementia made positive changes, specifically reliable reductions in psychological distress, which were largely attributable to Acceptance and Commitment Therapy (ACT). Two clients remained unchanged. Discussion/Conclusion: Where change was achieved, the ACT-specific processes of values, committed action and acceptance, in combination with non-specific therapy factors including a strong client-carer relationship, existing client interests and individualised therapy adaptations, were facilitative of change. Hence, ACT may be feasible and effective by helping carers to better meet the needs of their loved ones with dementia. Future research to optimise ACT delivery in this population may be beneficial. Furthermore, the assessment of carer factors (e.g., their psychological flexibility, the client-carer relationship) may strengthen the evidence-base for systemic ACT-use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2020
CompletedFirst Posted
Study publicly available on registry
November 16, 2020
CompletedStudy Start
First participant enrolled
January 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 22, 2022
CompletedAugust 19, 2022
August 1, 2022
9 months
November 2, 2020
August 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in anxiety
Generalised anxiety disorder questionnaire (GAD-7), scored 0-21, where higher scores indicate a greater severity of anxiety.
Through study completion, up to 24 weeks
Change in depression
Patient health questionnaire (PHQ-9), scored 0-27, where higher scores indicate a greater severity of depression.
Through study completion, up to 24 weeks
Secondary Outcomes (4)
Change in psychological flexibility
Through study completion, up to 24 weeks
Change in wellbeing
Through study completion, up to 24 weeks
Change in client problems
Through study completion, up to 24 weeks
Change in therapeutic alliance
Through study completion, up to 12 weeks
Study Arms (1)
Acceptance and Commitment Therapy
EXPERIMENTAL12 weekly, 90 minute ACT sessions with person with dementia (with a review at week 6)
Interventions
There is no specific protocol for ACT with dementia, therefore a published ACT protocol, 'Better Living with Illness' (Brassington et al., 2016), will be used flexibly to guide the intervention.
Eligibility Criteria
You may qualify if:
- Participants were included in the study if they had:
- A clinical diagnosis of dementia (any type)
- A clinically significant level of psychological distress (a score of ≥8 on the GAD-7 and ≥10 on the PHQ-9).
- Ability to give informed consent
- Participants were included in the study if they:
- Cared for someone with a clinical diagnosis of dementia (any type)
- Were paid or unpaid and regularly supported them with activities of daily living
- Aged 18+ (no maximum age limit)
- Able to give informed consent
You may not qualify if:
- Participants were excluded if they:
- Were already receiving psychotherapy
- Had insufficient English or language abilities to engage in therapy
- Were unable to consent to and/or engage in therapy
- Participants were excluded if they:
- Had insufficient English or language abilities to support the person with dementia or engage in study/Change Interviews
- Were unable to consent to and/or engage in study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nottinghamlead
- Nottinghamshire Healthcare NHS Trustcollaborator
Study Sites (1)
Community Mental Health Team for Older People
Newark, Nottinghamshire, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Danielle De Boos, Dr
University of Nottingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2020
First Posted
November 16, 2020
Study Start
January 20, 2021
Primary Completion
October 14, 2021
Study Completion
July 22, 2022
Last Updated
August 19, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- July 2022
The study data was written up as part of the student Doctoral Thesis and will be submitted in partial fulfilment of the requirements for the Trent Doctorate in Clinical Psychology (DClinPsy) in February 2022. Participants chose a pseudonym for themselves to be used in publications (e.g. electronic documents, written notes and transcripts) to prevent identification and references to personal information (e.g. other people's names, locations) were altered.